Skip to main content
. 2022 Jan 19;2022:8299218. doi: 10.1155/2022/8299218

Table 3.

Presence of safety-related information on medication package inserts (n = 200).

Variables Frequency Percentage
Adverse drug reactions 191 95.5
Contraindications 189 94.5
Drug-drug interactions 160 80.0
Drug-food interactions 42 21.0
Pregnancy considerations 154 77.0
Lactation considerations 148 74.0
Pediatric considerations 141 70.5
Geriatric considerations 75 37.5
Special warning and precautions 99 49.5
Abuse/dependence property 7 3.5
Effect on the ability to drive and operate machines 69 34.5
Overdose and management 139 69.5
Maximum dose 54 27.0
Missing dose 52 26.0
Handling and disposal 45 22.5

Example: renal, hepatic, cardiac, or nutritional insufficiencies that require either increased or reduced dosage.